2018, Número 1
Hepatic Hydrothorax
Idioma: Ingles.
Referencias bibliográficas: 131
Paginas: 33-46
Archivo PDF: 205.52 Kb.
RESUMEN
Sin resumen.REFERENCIAS (EN ESTE ARTÍCULO)
104.Riggio O, Angeloni S, Salvatori FM, De Santis A, Cerini F, Farcomeni A, Attili AF, et al. Incidence, natural history, and risk factorsof hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene- covered stent grafts. Am J Gastroenterol 2008; 103: 2738-46.
131.Park SZ, Shrager JB, Allen MS, Nagorney DM. Treatment of refractory, nonmalignant hydrothorax with a pleurovenous shunt. Ann Thorac Surg 1997; 63: 1777-9. 132.Artemiou O, Marta GM, Klepetko W, Wolner E, Muller MR. Pleurovenous shunting in the treatment of nonmalignant pleural effusion. Ann Thorac Surg 2003; 76: 231-3. 133.Hadsaitong D, Suttithawil W. Pleurovenous shunt in treating refractory nonmalignant hepatic hydrothorax: a case report. Respir Med 2005; 99: 1603-05. 134.Perera E, Bhatt S, Dogra VS. Complications of Denver shunt. J Clin Imaging Sci 2011; 1: 6. 135.Krowka MJ, Wiesner RH, Heimbach JK. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward. J Hepatol 2013; 59: 367-74. 136.Xiol X, Tremosa G, Castellote J, Gornals J, Lama C, Lopez C, Figueras J. Liver transplantation in patients with hepatic hydrothorax. Transpl Int 2005; 18: 672-5. 137.Serste T, Moreno C, Francoz C, Razek WA, Paugham C, Belghitti J, Valla D, et al. The impact of preoperative hepatic hydrothorax on the outcome of adult liver transplantation. Eur J Gastroenterol Hepatol 2010; 22: 207-12. 138.Endo K, Iida T, Yagi S, Yoshizawa A, Fujimoto Y, Ogawa K, Ogura Y, et al. Impact of preoperative uncontrollable hepatic hydrothorax and massive ascites in adult liver transplantation. Surg Today 2014; 44: 2293-9. 139.Bozbas SS, Eyuboglu F. Evaluation of liver transplant candidates: A pulmonary perspective. Ann Thorac Med 2011; 6: 109-14.